The efficiency of NER can influence the effectiveness of certain cancer therapies. For example, some chemotherapeutic agents, like cisplatin, create DNA adducts that are usually repaired by NER. Tumors with defective NER pathways may be more sensitive to these treatments. Conversely, enhanced NER activity in cancer cells can lead to resistance to therapy, posing a significant challenge.
